Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged cafc · clear
On September 20, 2016, the U.S. Court of Appeals for the Federal Circuit issued an opinion affirming the summary judgement that Abbott’s U.S. Patent No. 5,344,915 (“the ’915 Patent”) was sufficiently supported by the written…
The Federal Circuit recently decided two related cases concerning media content delivery patents 1 owned by Affinity Labs of Texas, LLC. In both cases, the Federal Circuit held that the patents do not cover patent-eligible subject matter under 35 U.S.C.…
Is claim construction an issue of law to be decided de novo on appeal, or are there relevant issues of fact, justifying that deference be given to the decisions and opinions of trial courts? The CAFC has recently denied a petition for en banc rehearing of…
